← Leaderboards
Maxim Totrov
Molsoft, Llc
$3,378,324
Attributed
$4,774,232
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2006–11$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$4,774,232 · 8
By mechanism
RC2$2,093,862 · 1
R43$1,995,581 · 4
R42$484,789 · 1
R41$200,000 · 2
Top collaborators
- Timothy J Cardozo1 shared
- Avi Ma'Ayan1 shared
Others in their field
Top investigators on “Computer Simulation”
- Daniel Stanzione · Arizona State University$135,429,468
- Omar N Ghattas · Carnegie Mellon University$128,934,182
- John E West · University Of Texas At Austin$110,966,494
- Kelly P Gaither · Purdue University$107,336,031
- Roger T Howe · University Of California-Berkeley$92,406,769
- Daniel C Ralph · Cornell University$89,901,072
Research focus
Computer SimulationComplexStructureLibrariesLigandsProteinsPublic Health RelevanceSuccessFlexibilityBenchmarkingPerformanceBaseMolecular ModelingMolecular ModelsProtein StructureDockingScreening ProcedureSmall MoleculeVirtualProceduresDrug Design /Synthesis /ProductionComputer SoftwareDrug DiscoveryLead
Grant awards (12)
Glycoprotein Modeling System for Internal Coordinate Mechanics$199,542
R43 · FY2011 · GM · contact PI
A Chemical Biology Network for Personalized Medicine$2,093,862
RC2 · FY2010 · LM
Computer-assisted identification and design of subtype selective GPCR antagonist$247,470
R43 · FY2010 · MH · contact PI
Glycoprotein Modeling System for Internal Coordinate Mechanics$199,705
R43 · FY2010 · GM · contact PI
Computer-assisted identification and design of subtype selective GPCR antagonist$250,000
R43 · FY2009 · MH · contact PI
Next Generation Forcefield for Internal Coordinate Mechanics$100,000
R41 · FY2009 · GM · contact PI
Integrated Protein Surface Annotation Suite$100,000
R43 · FY2006 · GM · contact PI
Rational Design of Inhibitors of Yersinia pestis EF-Tu$499,432
R43 · FY2004 · AI
Rational Development of Thyroid Receptor Antagonists$242,424
R42 · FY2004 · DK
Rational Development of TCF/Beta-Catenin Antagonists$100,000
R41 · FY2004 · CA
Rational Design of Inhibitors of Yersinia pestis EF-Tu$499,432
R43 · FY2003 · AI
Rational Development of Thyroid Receptor Antagonists$242,365
R42 · FY2003 · DK